European Hemostats Market by IndustryARC

European Hemostats Market By Materials, By Product, By Preparation Method, By Application and By Geography Analysis - Forecast 2019 - 2024 www.industryarc.com

European Hemostats Market 2019-2024

sales@industryarc.com

Industry Market Research for Business Leaders, Strategists, Decision Makers

Press Release Rising number of surgeries in Europe is boosting the sales of hemostats in the region as hemostats play a crucial part to control bleeding and reduce the loss of blood. According to the analyst from IndustryARC, European hemostats market is expected to attain a valuation of $1,320.9 million by the end of 2023 as the demand for the same in various countries of Europe will observe CAGR of 4.2% during the forecast period 2018-2023. The report has provided an assessment of all the major players in the European hemostats market along with a peek into their business strategies and revenue share. Furthermore, the analyst has depicted the trends, opportunities, and challenges with relevant facts, figures, and statistics that will provide a clear picture of the dynamics in European hemostats market. The report is titled, “ European Hemostats Market: By Type (Thrombin Based, Gelatin Based and Others); By Treatment (Cardiac Surgery, Vascular Procedures); By End Users (Hospitals, Surgery Centre and Others) & By Region - Forecast (2018-2023).” European Hemostats Market: Leading Segments In 2017, the UK had the maximum revenue share in European hemostats market with the regional sales that was translated to $131.96 million. This is attributable to the prevalence of obesity in the country. Furthermore, passive hemostats witness better revenue than other segments, as hemostats are hugely adopted by private and public hospitals for the safety of patients during the course of treatment. The UK was followed by Ireland and Germany in terms of revenue. The report gives a detailed analysis of all the segments of European hemostats market with their revenue shares with facts and figures that support the argument. There are different types of hemostats that include active, passive, flowable, sealants, and adhesives. According to the segmental scrutiny done by the analyst, the passive hemostats observed more revenue over other types. As they are relatively easier to prepare and inexpensive compared to their active counterparts. However, for arterial bleeding during surgeries, active ones are more effective. The revenue generation in Europe hemostats market from the sales of passive hemostats is expected to observe a healthy CAGR of 6.1% through 2023. European Hemostats Market: Trends and Growth Drivers · The Preference for Minimally Invasive Procedure – Minimally invasive procedures are used to treat diseases such as cancer, cardiac arrhythmias, and dermatological conditions. Furthermore, it is also used to treat critical and inoperable patients. There will be an increase in the number of minimally invasive procedures in European countries, which will support the market growth. · Fibrin Sealants to Observe Growth Prospects in European Hemostats Market –

European Hemostats Market

Fibrin sealants are considered as an adjunct to patients that are undergoing hemostasis. The increasing number of patients undergoing hemostasis are poised to increase European hemostats market revenue due to its subsequent surge in sales of fibrin sealants. Âˇ The Problem of Tissue Contamination with Previous Sealants â&#x20AC;&#x201C; There are innovations in European hemostats market; new tissue sealants and hemostats have addressed the problem of tissue contamination with sealants that were previously used and nontoxic and inexpensive from nature. These innovations are boosting the sales in European hemostats market. European Hemostats Market: Competitive Landscape Some of the key companies identified in European hemostats market intelligence report that are striving to capitalize on customer-base are Johnson & Johnson Service Inc., C.R. Bard, Inc., Baxter International Inc., Braun Melsungen AG, Pfizer Inc., Vascular Solutions, Inc., Gelita Medical, Equimedical B.V., Integra Lifesciences Holdings Corporation, Z-Medica, LLC, Marine Polymer Technologies, Inc., Cryolife, Mallinckrodt Plc., RESORBA Medical GmbH, and Cohera Medical, Inc. Talk to one of our sales representative about the full report by providing your details in the link below: https://industryarc.com/support.php?id=18043 Related Reports: a) Hemostatic Agents Market

https://industryarc.com/Report/15189/hemostats-market.html b) Hemostats Market

https://industryarc.com/Report/18331/hemostats-market.html What can you expect from the report? The European hemostats market report is prepared with the main agenda to cover the following 20 points: 1. Market Size by Product Categories & Application &

11. Demand Analysis (Revenue Volume)

2. Market trends & Relevant Market Data

12. Country level Analysis

3. Manufacturer Landscape

13. Competitor Analysis

4. Distributor Landscape

14. Market Shares Analysis

5. Pricing Analysis

15. Value Chain Analysis

6. Top 10 End user Analysis

16. Supply Chain Analysis

7. Product Benchmarking

17. Strategic Analysis

Product

Developments

Landscape 9. Mergers & Acquisition Analysis

European Hemostats Market

18.

Current

Future

Market

Analysis 19. Opportunity Analysis

10. Patent Analysis

20. Revenue and Volume Analysis

Frequently Asked Questions: Q. Does IndustryARC provide customized reports and charge additionally for limited customization? Response: Yes, we can customize the report by extracting data from our database of reports and annual subscription databases. We can provide the following free customization: 1. Increase the level of data in application or end user industry. 2. Increase the number of countries in geography chapter. 3. Find out market shares for other smaller companies or companies which are of interest to you. 4. Company profiles can be requested based on your interest. 5. Patent analysis, pricing, product analysis, product benchmarking, value and supply chain analysis can be requested for a country or end use segment. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services. To request for a proposal, provide your details in the below link: https://industryarc.com/reports/request-quote?id=18043 Media Contact: Mr. Venkat Reddy Sales Manager Email 1: sales@industryarc.com Or Email 2: venkat@industryarc.com Contact Sales: +1-614-588-8538 (Ext-101) About IndustryARC: IndustryARC is a Research and Consulting Firm that publishes more than 500 reports annually, in various industries such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food and Beverages, Information Technology, and Life sciences and Healthcare.

European Hemostats Market

Industry Market Research for Business Leaders, Strategists, Decision Makers

Table of Contents 1. European Hemostats Market Overview 2. Executive Summary 3. European Hemostats Market Landscape 3.1. Market Share Analysis 3.2. Comparative Analysis 3.2.1. Product Benchmarking 3.2.2. End User profiling 3.2.3. Patent Analysis 3.2.4. Top 5 Financials Analysis 4. European Hemostats Market Forces 4.1. Market Drivers 4.2. Market Constraints 4.3. Market Challenges 4.4. Attractiveness of the Industry 4.4.1. Power of Suppliers 4.4.2. Power of Customers 4.4.3. Threat of New entrants 4.4.4. Threat of Substitution 4.4.5. Degree of Competition 5. European Hemostats Market â&#x20AC;&#x201C; Strategic Analysis 5.1. Value Chain Analysis 5.2. Pricing Analysis 5.3. Opportunities Analysis 5.4. Product/Market Life Cycle Analysis 5.5. Suppliers and Distributors 6. European Hemostats Market â&#x20AC;&#x201C; By Type 6.1. Introduction 6.2. Active 6.2.1. Thrombin Based Hemostat 6.2.1.1. Bovine Thrombin 6.2.1.2. Pooled Human Plasma Thrombin 6.2.1.3. Recombinant Thrombin 6.3. Passive 6.3.1. Collagen Based Hemostats 6.3.1.1. Microfibrillar Collagen Hemostat 6.3.1.2. Absorbable Collagen Hemostat Sponge 6.3.2. Oxidized Regenerated Cellulose 6.3.3. Gelatins 6.3.4. Polysacchride Hemospheres 6.4. Flowable 6.4.1. Bovine Gelatin + Pooled Human Thrombin 6.4.2. Bovine Gelatin + Other Thrombin Products 6.5. Sealants 6.5.1. Fibrin Sealants 6.5.2. Synthetic Sealants 6.5.3. Others 6.6. Adhesives 6.6.1. Polyethylene Glycol Hydrogels (PEG) 6.6.2. PEG + Trilysine Amine

European Hemostats Market

6.6.3. PEG + Human Serum Albumin 6.6.4. Liquid Monomers 7. European Hemostats Market - By Treatment 7.1. Introduction 7.2. Cardiac Surgery 7.3. Vascular Procedures 7.4. Soft Tissue Reconstructions 7.5. Spinal Procedures 7.6. Hepatic Resection 7.7. Others 8. European Hemostats Market - By End Users 8.1. Introduction 8.2. Hospitals 8.3. Surgery Centers 8.4. Nursing Homes 8.5. Others 9. European Hemostats Market - By Country 9.1. Europe 9.1.1. U.K. 9.1.2. Ireland 9.1.3. France 9.1.4. Germany 9.1.5. Spain 9.1.6. Italy 9.1.7. Netherlands 9.1.8. Belgium 9.1.9. Austria 9.1.10. Norway 9.1.11. Sweden 9.1.12. Finland 9.1.13. Sweden 9.1.14. Denmark 9.1.15. Switzerland 9.1.16. Portugal 9.1.17. Rest of Europe 10. Market Entropy 10.1. New Product Launches 10.2. M&Aâ&#x20AC;&#x2122;s, Collaborations, JVâ&#x20AC;&#x2122;s, Partnership 11. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio) 11.1. Johnson & Johnson Services, Inc. (U.S.) 11.2. C. R. Bard, Inc. (U.S.) 11.3. Baxter (U.S.) 11.4. B Braun Melsungen AG (Germany) 11.5. Pfizer Inc. (U.S.) 11.6. Vascular Solutions, Inc. (U.S.) 11.7. Gelita Medical GmbH (Germany) 11.8. Equimedical (Netherlands) 11.9. Integra Lifesciences Holdings Corporation (U.S.) 11.10. Z-Medica, LLC (U.S.) 11.11 Marine Polymer Technologies, Inc. (U.S.) 11.12 Company 12 11.13 Company 13 11.14 Company 14 11.15 Company 15 *More than 20 Companies are profiled in this Research Report* "*Financials would be provided on a best efforts basis for private companies" 12. Appendix 12.1. Abbreviations

European Hemostats Market

12.2. Sources 12.3. Research Methodology 12.4. Bibliography 12.5. Compilation of Expert Insights 12.6. Disclaimer

European Hemostats Market

Industry Market Research for Business Leaders, Strategists, Decision Makers

IndustryARC Solutions We cater to the pain points of our clients by providing the following solutions, which are targeted and address key issues specifically. Each of the business verticals is helpful to a client at various stages of their operational, managerial and strategic level plans. Syndicate Reports and Consulting (SRC) 1. Provide high quality analytical syndicated reports with key market insights, strategies and market forecasts for a specific industry or vertical of the clients. Constant tracking of industries and relations with experts helps us to predict and publish reports before our competitors as well as meet client needs proactively. Market Research and Data Analytics (MRDA) 2. Provide pure play data analytics services for ad-hoc and long-term engagement projects of clients with market research layered into the analysis. We are the only global company to offer this combination one-stop service to clients. Redundancies generally seen by procuring data, analytics services from multiple vendors is overcome by our solution. Competitive Landscape Analysis (CLA) 3. Provide company financial analysis, market share analysis, competitive landscape insights and market movements to clients. This is one of the most important pain point and key request from majority of our clients, for which we use our proprietary methodologies to provide accurate CLA data. Accelerated Business Development (ABD) 4. Connect clients with their customers on a global scale by acting as an outsourced sales team on behalf of the client. This is a unique tri-party engagement model to benefit the client and their customer, and acts as a business development scale up at an international level. Market Intel Reports (MIR) 5. Provide one-stop venue with a searchable syndicate reports database from global companies available to clients. This augments our offerings exponentially and also assists in studying global client needs at an in-depth level.

European Hemostats Market

Industry Market Research for Business Leaders, Strategists, Decision Makers

About IndustryARC IndustryARC strategy studies primarily focuses on Cutting Edge Technologies and Newer Applications of the Market. Our Custom Research Services are designed to provide insights on the constant flux in the global demand-supply gap of markets. Our strong analyst team enables us to meet the client research needs at a very quick speed with a variety of options for your business. We look forward to support the client to be able to better address customer needs; stay ahead in the market; become the top competitor and get real-time recommendations on business strategies and deals.

We Work for You For IndustryARC, we value every customer equally. We only stay ready to help each client in the best way possible with a unique 24x365 support plan. We suggest looking at the following benefits of relying on Professional Business Consulting and Custom Market Research Services to realize the unique strategic gains on offer: 1. 2. 3. 4. 5. 6. 7.

Strengthen and improve organizational performance Strategic planning and analysing Adoption of newer and cost-effective technologies Become environmentally sustainable and profitable Improve their training and certification procedures. Planning for business automation. Project facilitation and management.

European Hemostats Market

010